Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus Sep 9, 2010: Clinical and Regulatory PCR and Nucleic Acid Testing News

Premium

Myconostica said this week that its MycAssay Aspergillus test has received the CE mark for detecting Aspergillus spp. DNA in serum.

MycAssay Aspergillus is a molecular diagnostic assay designed to be used by laboratory professionals, and the results of the test aid physicians in diagnosing patients suspected of having an infection caused by Aspergillus, according to Manchester, UK-based Myconostica.

MycAssay Aspergillus previously received the CE mark for respiratory samples, meaning that the test is now CE marked for all major sample types. There are a number of high-risk patient groups for whom it is difficult to obtain respiratory samples, Myconostica said.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.